Flotats A, Carrió I, Estorch M, Bernà L, Catafau A M, Marí C, Ballester M
Department of Nuclear Medicine, Hospital de La Santa Creu i Sant Pau, Barcelona, Spain.
Eur J Nucl Med. 1997 Jul;24(7):767-73. doi: 10.1007/BF00879665.
A comparison was performed between technetium-99m tetrofosmin myocardial perfusion tomography at baseline and after nitrate administration, using a 2-day protocol, and rest-reinjection thallium-201 single-photon emission tomography (SPET) studies in order to assess whether nitrates enhance the detection of viable myocardium with 99mTc-tetrofosmin. Fifteen patients with coronary artery disease, previous myocardial infarction and a left ventricular ejection fraction <40% underwent 201Tl rest-injection and 99mTc-tetrofosmin baseline-postnitroglycerin (0.4 mg sublingually) SPET studies, within 48 h. Tomograms based on the three spatial planes were divided into 15 segments and regional tracer uptake was quantitatively analysed. Viability was defined as presence of tracer uptake >/=50% of peak activity on baseline studies or after reversibility. The percentage of peak activity of 99mTc-tetrofosmin at baseline correlated with that of 201Tl (r=0.82, P <0.001). On baseline 99mTc-tetrofosmin studies, 73 of the 225 segments that were analysed had <50% of peak activity. Fifteen percent of these segments showed reversibility after nitrate administration, with an increase in 99mTc-tetrofosmin uptake from 40%+/-9% to 57%+/-9% of peak activity (P=0.003). All reversible segments after nitrate administration had viability criteria on 201Tl studies, but 20 segments that were non-viable on 99mTc-tetrofosmin studies were viable on 201Tl studies. Using a threshold value of >/=40% of peak activity, only seven segments remained non-viable on 99mTc-tetrofosmin studies. Overall agreement between 99mTc-tetrofosmin with nitrates and 201Tl-reinjection regarding the presence of myocardial viability was 90%. Detection of myocardial viability with 99mTc-tetrofosmin was enhanced after nitrate administration, correlating with viability criteria observed on thallium studies.
采用两日方案,对99m锝替曲膦心肌灌注断层扫描在基线时和给予硝酸盐后进行比较,并与静息再注射铊-201单光子发射断层扫描(SPET)研究进行对比,以评估硝酸盐是否能增强99m锝替曲膦对存活心肌的检测。15例患有冠状动脉疾病、既往有心肌梗死且左心室射血分数<40%的患者在48小时内接受了铊-201静息注射和99m锝替曲膦基线-舌下含服硝酸甘油(0.4mg)后的SPET研究。基于三个空间平面的断层图像被分为15个节段,并对区域示踪剂摄取进行定量分析。存活定义为在基线研究或可逆性后示踪剂摄取> /=峰值活性的50%。99m锝替曲膦在基线时的峰值活性百分比与铊-201的峰值活性百分比相关(r = 0.82,P <0.001)。在基线99m锝替曲膦研究中,分析的225个节段中有73个节段的活性<50%峰值活性。这些节段中有15%在给予硝酸盐后显示可逆性,99m锝替曲膦摄取从峰值活性的40%±9%增加到57%±9%(P = 0.003)。给予硝酸盐后所有可逆节段在铊-201研究中符合存活标准,但99m锝替曲膦研究中20个无活性节段在铊-201研究中是有活性的。使用> /=峰值活性40%的阈值,99m锝替曲膦研究中只有7个节段仍无活性。99m锝替曲膦联合硝酸盐与铊-201再注射在心肌存活存在方面的总体一致性为90%。给予硝酸盐后,99m锝替曲膦对心肌存活的检测得到增强,与铊研究中观察到的存活标准相关。